(ELV) Elevance Health - Ratings and Ratios

Elevance Health, Inc. (NYSE:ELV) is a leading health benefits company in the United States, operating through four primary segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company provides a comprehensive range of health insurance plans and services, including individual, employer-sponsored, Medicare, Medicaid, and Federal Employees Program (FEP) coverage. It also offers specialty insurance products such as dental, vision, and supplemental health benefits. Additionally, Elevance Health operates in the pharmacy services sector, managing prescription drug benefits, home delivery, and specialty pharmacies, while providing claims adjudication, formulary management, and rebate administration. The company further extends its capabilities through healthcare-related services, including utilization management, behavioral health, virtual care, and payment integrity programs. These services are delivered through its HealthOS platform, which integrates clinical data exchange, analytics, and business process support. Elevance Health serves its customers under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. Formerly known as Anthem, Inc., the company rebranded as Elevance Health in June 2022 to reflect its expanded focus on integrated health solutions. Headquartered in Indianapolis, Indiana, Elevance Health has been in operation since 2001 and maintains a strong presence in the managed health care sector.

As of the latest data, Elevance Health has a market capitalization of $99.105 billion, with a price-to-earnings (P/E) ratio of 17.03 and a forward P/E of 12.69, indicating moderate valuation relative to earnings. The companys price-to-book (P/B) ratio stands at 2.40, reflecting its market value compared to book value. The price-to-sales (P/S) ratio of 0.56 suggests a lower valuation relative to revenue. Elevance Healths return on equity (RoE) is 14.47%, indicating efficient profitability. Technically, the stock is trading at $424.53, with a 20-day simple moving average (SMA) of $432.77 and a 50-day SMA of $413.69. The 200-day SMA is $447.76, while the average true range (ATR) is 13.75, reflecting moderate volatility. The stocks average 20-day volume is approximately 1.3 million shares.